<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>Trichomoniasis Quick-Reference</title>
<meta name="viewport" content="width=device-width,initial-scale=1">
<style>
:root{
  --nice:#005eb8;
  --light:#f3f7fd;
  --accent:#00a499;
  --text:#222;
  --muted:#555;
  --border:#d0d9e6;
  --radius:10px;
  --shadow:0 4px 12px rgba(0,0,0,.08);
}
*{box-sizing:border-box;margin:0;padding:0;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Helvetica,Arial,sans-serif}
body{background:var(--light);color:var(--text);padding:20px}
h1{color:var(--nice);margin-bottom:8px;font-size:28px}
h2{color:var(--accent);margin:20px 0 10px;font-size:20px}
.card{background:#fff;border-radius:var(--radius);box-shadow:var(--shadow);padding:24px;margin-bottom:20px}
.step{display:flex;align-items:flex-start;margin-bottom:16px}
.step .num{background:var(--nice);color:#fff;border-radius:50%;min-width:32px;height:32px;display:flex;align-items:center;justify-content:center;font-weight:700;margin-right:14px}
.step p{margin:0;line-height:1.45}
.table-wrapper{overflow-x:auto;margin-bottom:16px}
table{width:100%;border-collapse:collapse;font-size:14px}
th,td{padding:10px 12px;border-bottom:1px solid var(--border)}
th{background:var(--light);color:var(--nice);text-align:left}
ul{list-style:none;margin-left:0}
ul li::before{content:"•";color:var(--accent);display:inline-block;width:1em;margin-left:-1em}
footer{font-size:12px;color:var(--muted);text-align:center;margin-top:30px}
@media(max-width:600px){
  h1{font-size:24px}
  .card{padding:18px}
}
</style>
</head>
<body>

<h1>Trichomoniasis Quick-Reference Algorithm</h1>
<small>NICE CKS – December 2024</small>

<div class="card">
  <h2>1. Is Trichomoniasis Likely?</h2>
  <ul>
    <li><strong>Women:</strong> frothy green-yellow discharge, vulval itch, dysuria, odour (↑pH &gt; 4.5)</li>
    <li><strong>Men:</strong> urethral discharge ± dysuria (often asymptomatic)</li>
    <li><strong>Risk flags:</strong> new/multiple partners, co-existing STI, BV, inconsistent condom use</li>
  </ul>
</div>

<div class="card">
  <h2>2. Immediate Action</h2>
  <div class="step">
    <div class="num">1</div>
    <p><strong>All symptomatic or exposed patients</strong> → offer <strong>GUM referral</strong></p>
  </div>
  <div class="step">
    <div class="num">2</div>
    <p>If declined / unavailable → proceed with <strong>primary-care testing</strong></p>
  </div>
</div>

<div class="card">
  <h2>3. Point-of-Care Tests</h2>
  <div class="table-wrapper">
    <table>
      <thead>
        <tr>
          <th></th>
          <th>Women</th>
          <th>Men</th>
        </tr>
      </thead>
      <tbody>
        <tr>
          <td><strong>Sample</strong></td>
          <td>Self-taken vaginal swab <em>(preferred)</em><br>OR high vaginal swab</td>
          <td>First-void urine <em>or</em> urethral / penile-meatal NAAT swab</td>
        </tr>
        <tr>
          <td><strong>Lab</strong></td>
          <td colspan="2">NAAT (gold); wet microscopy if available</td>
        </tr>
      </tbody>
    </table>
  </div>
  <p><strong>Add-ons:</strong> Triple STI screen (Chlamydia, Gonorrhoea, HIV ± Syphilis, Hep B/C if high-risk)</p>
</div>

<div class="card">
  <h2>4. Treatment – START SAME DAY</h2>
  <div class="table-wrapper">
    <table>
      <thead>
        <tr>
          <th>Patient Group</th>
          <th>Regimen</th>
          <th>Notes</th>
        </tr>
      </thead>
      <tbody>
        <tr>
          <td>Non-pregnant / non-breastfeeding</td>
          <td>Metronidazole 400–500 mg PO BD × 7 d <br><em>or</em> 2 g single dose</td>
          <td>Avoid alcohol 48 h post-dose</td>
        </tr>
        <tr>
          <td>Pregnant + symptomatic</td>
          <td>Metronidazole 400 mg PO BD × 7 d</td>
          <td>High-dose single dose <strong>avoided</strong></td>
        </tr>
        <tr>
          <td>Breastfeeding</td>
          <td>Same as pregnant</td>
          <td>Dose after feed, discard milk 12–24 h</td>
        </tr>
        <tr>
          <td>HIV co-infection</td>
          <td>Metronidazole 500 mg PO BD × 7 d</td>
          <td></td>
        </tr>
      </tbody>
    </table>
  </div>
  <p><strong>Partners:</strong> Treat <em>all</em> sexual partners within 4 weeks <em>simultaneously</em></p>
</div>

<div class="card">
  <h2>5. Follow-Up & Red Flags</h2>
  <ul>
    <li>Abstain from sex until <strong>1 week after treatment finished</strong> for patient <em>and</em> partner(s)</li>
    <li>Test-of-cure <strong>only if symptoms persist / recur</strong> (≥48 h post-treatment)</li>
    <li>Persistent symptoms → check adherence + reinfection → <strong>GUM referral</strong></li>
    <li>Pregnant / recurrent / treatment-failure cases → <strong>GUM specialist review</strong></li>
  </ul>
</div>

<footer>
  © NICE CKS – December 2024 | For NHS primary-care clinicians
</footer>

</body>
</html>